[Elevated Level of the Natriuretic Peptide Among Adult Population in Regions Participating in the ESSE-RF Study and Its Association With Cardiovascular Diseases and Risk Factors]

Kardiologiia. 2017 Dec;57(12):43-52.
[Article in Russian]

Abstract

Aim: to study associations between elevated blood plasma concentration of N-terminal pro-brain natriuretic peptide (NT-proBNP), risk factors and cardiovascular diseases (CVD) in samples of adult population of Russian Federation (RF) aged 25-64 years.

Materials and methods: We analyzed data of examination of representative samples of population of 5 regions of RF obtained within the framework of the multicenter ESSE-RF study (2012-2013). Number of examined subjects was 8 077 (3 176 men). Methods included use of standard questionnaire, measurements of height, body mass, blood pressure (BP), and plasma NT-proBNP level. The following CVD were included into analysis: arterial hypertension (AH), ischemic heart disease (IHD), atrial fibrillation (AF), and stroke.

Results: Women compared to men had higher NT-proBNT concentration was higher in women compared to men, in both genders it rose with age. Overall 17.9 % of examinees had elevated NT-proBNT levels (14.2 and 20.3 % among men and women, respectively). Elevated NTproBNP level was associated in men with age, myocardial infarction, angina pectoris, ischemic ECG changes, left ventricular hypertrophy, AF, bradycardia, smoking, in women with age, IHD, ischemic ECG changes, AF, bradycardia, heart rate ≥80 bpm, BP ≥160/95 mm Hg.

Conclusion: In studied RF population elevated NT-proBNP level was significantly associated with gender, age, smoking, and CVD.

Keywords: RF population; brain natriuretic peptide; cardiovascular diseases.

MeSH terms

  • Adult
  • Biomarkers
  • Cardiovascular Diseases*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain
  • Natriuretic Peptides
  • Peptide Fragments
  • Risk Factors
  • Russia

Substances

  • Biomarkers
  • Natriuretic Peptides
  • Peptide Fragments
  • Natriuretic Peptide, Brain